Nonpharmacological response in hospitalized children with conduct disorder

Area of Science:

• Child and Adolescent Psychiatry
• Behavioral Sciences
• Clinical Psychology

Background:

• Limited research exists on the impact of hospitalization and placebo response in pediatric conduct disorder (CD) with severe aggression.
• Children with CD are often immediately prescribed pharmacotherapy upon hospitalization, potentially confounding treatment efficacy assessments.

Purpose of the Study:

• To investigate the effects of hospitalization and placebo administration on aggression in hospitalized children with conduct disorder.
• To examine the response to placebo in pediatric conduct disorder patients before initiating active pharmacotherapy.

Main Methods:

• A 4-week double-blind, placebo-controlled study involving 44 children (ages 9.83-17.14) with conduct disorder and severe aggression.
• A 2-week single-blind placebo lead-in period with 24-hour aggression monitoring using the Overt Aggression Scale.
• Randomization to treatment phase only for subjects meeting specific aggression criteria during the placebo baseline.

Main Results:

• Over half (52.3%) of enrolled subjects met criteria for the treatment period (baseline nonresponders).
• Nearly half (47.7%) did not meet criteria (baseline responders), indicating improvement with inpatient milieu/structure and/or placebo.
• A significant portion of children showed improvement without active medication.

Conclusions:

• Immediate pharmacotherapy initiation upon hospitalization for aggression in conduct disorder may lead to inaccurate attribution of improvement.
• A placebo baseline period is crucial to differentiate treatment effects from milieu effects and avoid unnecessary medication.
• Implementing a placebo phase can reduce the risk of Type II errors in aggression-related pharmacological research.